Zoono Group Ltd (ASX: ZNO) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Zoono Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$20.31 million
P/E Ratio
28.90
Dividend Yield
0.00%
Shares Outstanding
406.21 million
Earnings per share
-0.009
Dividend per share
0.03
Year To Date Return
-32.91%
Earnings Yield
3.46%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Zoono Group Ltd (ASX: ZNO)
Latest News
Share Market News
3 ASX biotech shares that have soared higher today
Coronavirus News
How this small cap ASX biotech company is helping the fight against coronavirus
Technology Shares
Why you should add this ASX tech share to your 2020 watchlist
Coronavirus News
Coronavirus: Why this small cap ASX biotech share jumped 12% higher
Share Market News
Here's why the Zoono share price zoomed 13% higher today
Share Market News
Why this small-cap ASX healthcare share surged 24% today
Share Gainers
These ASX shares are fighting the spread of coronavirus
Share Market News
Why the Zoono share price has skyrocketed 250% in 2020
Share Market News
Why the Zoono share price rocketed another 19% higher today
Share Gainers
Why Amaysim, Freedom Foods, NEXTDC, & Zoono are pushing higher
Coronavirus News
Zoono share price rockets 28% on coronavirus test results
Share Market News
These 3 ASX healthcare shares could make you rich
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Sep 2020 | $0.0300 | 0.00% | Final | 21 Sep 2020 |
ZNO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Zoono Group Ltd
Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.
ZNO Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 23 Mar 2026 | $0.05 | $0.00 | 0.00% | 90,374 | $0.05 | $0.05 | $0.05 |
| 20 Mar 2026 | $0.05 | $0.00 | 0.00% | 106,481 | $0.05 | $0.05 | $0.05 |
| 19 Mar 2026 | $0.05 | $0.00 | 0.00% | 43,523 | $0.05 | $0.06 | $0.05 |
| 18 Mar 2026 | $0.05 | $0.00 | 0.00% | 100,548 | $0.06 | $0.06 | $0.05 |
| 17 Mar 2026 | $0.05 | $0.00 | 0.00% | 33,696 | $0.06 | $0.06 | $0.05 |
| 16 Mar 2026 | $0.05 | $0.00 | 0.00% | 15,596 | $0.05 | $0.05 | $0.05 |
| 13 Mar 2026 | $0.05 | $0.00 | 0.00% | 75,232 | $0.05 | $0.05 | $0.05 |
| 12 Mar 2026 | $0.05 | $0.00 | 0.00% | 224,471 | $0.05 | $0.06 | $0.05 |
| 11 Mar 2026 | $0.06 | $0.00 | 0.00% | 56,072 | $0.05 | $0.06 | $0.05 |
| 09 Mar 2026 | $0.06 | $0.00 | 0.00% | 53,500 | $0.06 | $0.06 | $0.06 |
| 06 Mar 2026 | $0.06 | $0.00 | 0.00% | 51,036 | $0.06 | $0.06 | $0.06 |
| 05 Mar 2026 | $0.06 | $0.00 | 0.00% | 135,738 | $0.05 | $0.06 | $0.05 |
| 04 Mar 2026 | $0.05 | $-0.01 | -16.95% | 42,081 | $0.06 | $0.06 | $0.05 |
| 02 Mar 2026 | $0.06 | $0.00 | 0.00% | 69,300 | $0.06 | $0.06 | $0.06 |
| 27 Feb 2026 | $0.06 | $0.00 | 0.00% | 103,189 | $0.06 | $0.06 | $0.06 |
| 26 Feb 2026 | $0.06 | $0.00 | 0.00% | 55,830 | $0.06 | $0.06 | $0.06 |
| 25 Feb 2026 | $0.06 | $0.01 | 18.87% | 27,489 | $0.05 | $0.06 | $0.05 |
| 24 Feb 2026 | $0.05 | $-0.01 | -14.93% | 279,341 | $0.07 | $0.07 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Aug 2025 | Donald Clarke | Issued | 72,322 | $2,531 |
Rights issue.
|
| 05 Aug 2025 | Elissa Hansen | Issued | 71,518 | $2,503 |
Rights issue.
|
| 05 Aug 2025 | Paul Hyslop | Issued | 14,921,072 | $522,237 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Donald Ian Clarke | Non-Executive Director | Apr 2017 |
Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group from 1988 until 2015. He is currently a consultant for the firm. Don has advised corporate clients on broad corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He is able to draw on his first-hand experience as a corporate lawyer and a company director in guiding the Company and the Board on the duties and responsibilities of the Directors and the best practice in corporate governance. He is the Chairman of the Risk Committee.
|
| Ms Elissa Hansen | Company SecretaryNon Executive Director | Aug 2015 |
Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings practice governance advice, ensuring compliance with the Listing Rules, Corporations Act and other relevant legislation. She is a member of the Risk Committee.
|
| Mr Paul Hyslop | Managing Director | Apr 2017 |
Mr Hyslop prior to establishing Zoono, Paul was involved in several entrepreneurial ventures ranging from the establishment of a private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002 - 2005. Adept at dealing with businesses and consumers alike, he co-established the Business Brokerage Division at Bayley's Real Estate - real estate and business brokerages in New Zealand. Paul's experience in business development dates to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
|
| Mr Marc Braterman | Non-Executive Director | Feb 2026 |
Mr Braterman is the Founder and Chief Executive Officer of OSY Group Limited. Marc has worked closely with Zoonos management team throughout this development phase, contributing to product strategy, commercial positioning, and partner engagement.
|
| Mr Barry Woolcott | Global General ManagerChief Executive Officer | Mar 2022 |
-
|
| Paul Ravlich | Chief Financial Officer |
-
|
|
| Lew Mackinnon | Chief Operations Officer |
-
|
|
| Barry Woolcott | Global General ManagerChief Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Paul Russell Hyslop & Margaret Jane Morgan & Npt Meg Trustee Limited <Meg A/C> | 104,447,500 | 29.39% |
| Citicorp Nominees Pty Limited | 48,494,639 | 13.64% |
| BNP Paribas Noms Pty Ltd | 44,232,321 | 12.45% |
| Mrs Barbara Diane Wiersma & Mr Eelco Wiersma | 17,493,204 | 4.92% |
| Mr Theophilos Papantoniou | 4,975,180 | 1.40% |
| Marissa Tacy Muirhead | 4,118,889 | 1.16% |
| Sharesies Australia Nominee Pty Limited | 4,042,294 | 1.14% |
| Lewis Andrew Craig Mackinnon | 3,867,131 | 1.09% |
| HSBC Custody Nominees (Australia) Limited Gsco Eca | 3,619,340 | 1.02% |
| Lordmax Pty Ltd <Al Fund A/C> | 3,600,000 | 1.01% |
| Ms Marie Tania Adams | 3,572,155 | 1.00% |
| Ravlich Trustee Limited | 2,828,023 | 0.80% |
| Mr Andrew Lozynsky | 2,200,000 | 0.62% |
| Mr Libor Jelenek | 2,000,000 | 0.56% |
| Mr Ronald Duje Vela | 1,951,852 | 0.55% |
| Woolcott Investments Limited <The Woolcott Investment A/C> | 1,886,792 | 0.53% |
| Mr Martin Hunt | 1,716,204 | 0.48% |
| Mr Eelco Wiersma & Mr Malcolm Hinman <Christchurch United A/C> | 1,700,000 | 0.48% |
| Leslie Allan Black | 1,388,889 | 0.39% |
| Mr Shaileshkumar Shankarbhai Patel | 1,341,372 | 0.38% |